Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoxsuprine HCL with Steroids for MS Relapse
NCT03752307Phase 2Completed
- Sponsor
- The University of New Mexico
- Start
- Feb 2019
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple sclerosis (MS) comparing Corticosteroid & Isoxsuprine HCL with Corticosteroid & Placebo (2 arms). Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 12 weeks. Started Feb 2019; status: completed.
02
Drugs
isoxsuprine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03752307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03752307.